BRIEF published on 12/18/2025 at 22:10, 10 months 19 days ago Abivax rejoint l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 10 months 19 days ago Abivax joins the Nasdaq Biotechnology index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 10 months 19 days ago Abivax intègre l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Indice Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 10 months 19 days ago Abivax Joins Nasdaq Biotechnology Index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology Index
PRESS RELEASE published on 12/18/2025 at 22:05, 10 months 19 days ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'Indice Biotechnologie du Nasdaq, témoignant de sa croissance et de ses avancées cliniques. Le NBI suit les performances des sociétés du secteur Biotechnologie Abivax Nasdaq Clinique NBI
PRESS RELEASE published on 12/18/2025 at 22:05, 10 months 19 days ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'indice Nasdaq Biotechnology, rejoignant le NBI avec impact le 22 décembre 2025. Un pas significatif pour la société de biotechnologie française Biotechnologie Abivax France Nasdaq Biotechnology Indice
PRESS RELEASE published on 12/18/2025 at 22:05, 10 months 19 days ago Abivax to be Added to Nasdaq Biotechnology Index Abivax to be added to Nasdaq Biotechnology Index, reflecting company's progress in developing therapeutics for chronic inflammatory diseases. Inclusion effective December 22, 2025 Biotechnology Abivax Therapeutics Immune Response Nasdaq Biotechnology Index
BRIEF published on 12/17/2025 at 22:10, 10 months 20 days ago Abivax : 22 Abstracts sur Obefazimod Présentés à l'ECCO 2026 Abivax Obefazimod Efficacité Fibrose MICI
BRIEF published on 12/17/2025 at 22:10, 10 months 20 days ago Abivax: 22 Abstracts on Obefazimod Presented at ECCO 2026 Abivax Obefazimod Efficiency Fibrosis IBD
BRIEF published on 12/17/2025 at 22:10, 10 months 20 days ago Abivax dévoile de nouvelles données sur l'obefazimod à l'ECCO 2026 Abivax Obefazimod Rectocolite Hémorragique ECCO 2026 Antifibrotique
Published on 11/06/2026 at 22:15, 1 hour 1 minute ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 10 hours 16 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 10 hours 46 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 10 hours 46 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 3 hours 1 minute ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 3 hours 1 minute ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 4 hours 1 minute ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 4 hours 16 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 4 hours 44 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 19:06, 4 hours 10 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 4 hours 12 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 4 hours 15 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 4 hours 16 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
